July 31, 2018
Genmab has once again retained The Chase Group with a new request to assist with the continued growth of their Translational Research team. The Chase Group is currently seeking a Director/Senior Director, Late-Stage Translational Research Leader with strong management skills and the cross-functional dexterity to actively engage with all levels and functions to drive the development of innovative products and solutions. As a leading international biotechnology company, Genmab aims to improve the lives of cancer patients by creating and developing innovative antibody products. The Chase Group is honored to assist Genmab in finding high caliber talent with the passion, determination, and integrity to deliver on that mission. For more information, contact ken@chasegroup.com
